iBio (IBIO) Current Deferred Revenue (2015 - 2026)
iBio (IBIO) reported Current Deferred Revenue of $1.15 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 4.2% from $1.2 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Current Deferred Revenue (2015 - 2026) Analysis & Trends
Dating back to fiscal Q2 2019, iBio's Current Deferred Revenue record includes 27 quarters.
- Current Deferred Revenue has a five-year compound annual growth rate of 22.1% (FY2021 to FY2026).
- By fiscal year, Current Deferred Revenue came in at $1.2 million in FY2025 (+500.0%), $200,000 in FY2024 and $100,000 in FY2022 (-76.4%).
- Five-year quarterly Current Deferred Revenue spans a low of $8,000 in fiscal Q3 2022 and a high of $1.2 million in fiscal Q4 2025.
- Year over year, Current Deferred Revenue gained in five of the last six quarters, with growth averaging 184.9%.
- The high point for year-over-year Current Deferred Revenue in five years was fiscal Q4 2025 (growth of 500.0%); the low point was fiscal Q3 2022 (a decline of 99.1%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $1.15 million (Q3 2026), $1.15 million (Q2 2026) and $1.15 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | iBio | 118.23 Mn | -174.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 200,000.00 |
| Jun 30, 2026 | 1.15 Mn |
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 1.15 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 600,000.00 |
| Sep 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 175,000.00 |
| Dec 31, 2022 | 88,000.00 |
| Sep 30, 2022 | 161,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Dec 31, 2021 | 60,000.00 |
| Sep 30, 2021 | 94,000.00 |
| Jun 30, 2021 | 423,000.00 |
| Mar 31, 2021 | 886,000.00 |
| Dec 31, 2020 | 1.23 Mn |
API Access
iBio Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();